High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 13-1-2026, 23:46